Examining how environmental factors affect gut bacteria in infants
The Mechanism of Interaction Between Arsenic Exposure and Gut Microbiota in Infants During Early Life
This study is looking at how different environmental factors affect the gut bacteria of newborns to better understand their development.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 756 (estimated) |
| Ages | 1 Day to 24 Months |
| Sex | All |
| Sponsor | Peking University People's Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06479928 on ClinicalTrials.gov |
What this trial studies
This observational study aims to recruit mothers and their infants born at Peking University People's Hospital from 2023 to 2026 to investigate the interactions between environmental exposures and gut microbiota during early life. The study will focus on assessing how various environmental factors may influence the development of gut bacteria in newborns. By analyzing data collected from this cohort, researchers hope to gain insights into the role of these interactions in infant development.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women aged 20-40 years with a single pregnancy and a gestational age of at least 36 weeks.
Not a fit: Patients with serious congenital diseases or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of how environmental factors influence gut health in infants, potentially leading to improved health outcomes.
How similar studies have performed: While the specific interactions between environmental exposures and gut microbiota in infants are still being explored, similar studies have shown promising results in understanding gut health and its implications for development.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Pregnant woman * aged 20-40 years old * natural conception * single pregnancy * gestational age ≥36 weeks 2. Newborn * normal Apgar score * no serious congenital diseases Exclusion Criteria: \-
Where this trial is running
Beijing
- The Peking University People's Hospital — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Xue Xu, Dr.
- Email: xuxue19877182@sina.com
- Phone: 010-88324385
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.